sparsentan will reduce the extent or effect of modafinil by affecting hepatic enzyme CYP2C19 metabolism. Use Warning/Observe. Sparsentan (a CYP2C19 inducer) decreases publicity of CYP2C19 substrates and reduces efficacy associated with these substrates. modafinil will lessen the level or outcome of fruquintinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid https://modafinil35677.blogsumer.com/25903782/how-modafinil-can-save-you-time-stress-and-money